公开(公告)号：US20230092904A1

公开(公告)日：2023-03-23

申请号：US17990863

申请日：2022-11-21

申请人： Arjuna Natural Private Limited

发明人： Benny ANTONY

IPC分类号： A61K36/81 ,  A61K9/16 ,  A61K9/20 ,  A61K9/50 ,  A61K36/21 ,  A61K9/14 ,  A61K9/28 ,  A61K36/185 ,  A61K36/23 ,  A61K36/47 ,  A61K36/48 ,  A61K36/53 ,  A61K36/534 ,  A61K36/54 ,  A61K36/67 ,  A61K36/71 ,  A61K36/82 ,  A61K36/87 ,  A61K36/9066 ,  A61K36/9068

摘要： A unit dosage of an oral composition of an extract of Withania somnifera is disclosed. The extract of Withania somnifera includes total withanolides. The total withanolides includes withanolide glycosides and withanolide aglycones. The extract of Withania somnifera includes about 32% to about 38% by weight of the withanolide glycosides. Methods of preparing the extract of Withania somnifera are disclosed. Methods of treatment by administering the extract of Withania somnifera are disclosed.

公开(公告)号：US11607439B2

公开(公告)日：2023-03-21

申请号：US16983715

申请日：2020-08-03

申请人： HERBALIFE INTERNATIONAL, INC.

发明人： Bruce L. Howe

IPC分类号： A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K9/127 ,  A61K31/685 ,  A61K31/56 ,  A61K31/12 ,  A61K9/14

摘要： The invention is directed to natural drug compositions comprising turmeric, boswellia and ginger. Methods for the use of the inventive drug compositions in the treatment of inflammatory disorders and melanoma are within the scope of the invention.

公开(公告)号：US11596610B2

公开(公告)日：2023-03-07

申请号：US17199903

申请日：2021-03-12

申请人： Sovereignty

发明人： Jason Crawford

IPC分类号： A61K31/05 ,  A61K45/06 ,  A61K36/68 ,  A61K36/185 ,  A61K36/82 ,  A61K36/74 ,  A61K36/736 ,  A61K36/45 ,  A61K36/31 ,  A61K36/9066 ,  A61K31/522 ,  A61K36/79 ,  A61K31/4045 ,  A61K31/198 ,  A61K36/21 ,  A61K31/197 ,  A61K36/53 ,  A61K36/81

摘要： A composition includes a cannabinoid agent in a range of 0.005% to 1%, a terpene agent in a range of 0.005% to 1%, and a co-fermented herbal complex in a range of 5% to 40%. The cannabinoid agent can include CBD, CBN, CBG, or a combination thereof. The composition can further include ashwagandha.

公开(公告)号：US20230014170A1

公开(公告)日：2023-01-19

申请号：US17948968

申请日：2022-09-20

申请人： Alcresta Therapeutics, Inc.

发明人： Eric First ,  David Widom

IPC分类号： A61K9/48 ,  A61K9/50 ,  A61K9/24 ,  A61M31/00 ,  A61K45/06 ,  A61J3/07 ,  A61J7/00 ,  A61K31/12 ,  A61J1/20 ,  A61K31/05 ,  A61K31/122 ,  A61K36/9066 ,  A61K31/202 ,  A23L33/115 ,  A61K31/4045 ,  A23L33/12 ,  A61K31/198 ,  A61K33/06

摘要： Exemplary embodiments of the disclosure may be drawn to ingestible delivery devices. An ingestible delivery device may include a first compartment and a second compartment. A lipase may be contained within the first compartment, and a fat may be contained within the second compartment. The first compartment may be sealed from the second compartment prior to exposure to a trigger, preventing the lipase and the fat from contacting each other, and at least one of the first compartment or the second compartment may at least partially rupture upon exposure to the trigger, allowing the lipase and the fat to contact each other.

公开(公告)号：US11534393B2

公开(公告)日：2022-12-27

申请号：US16875648

申请日：2020-05-15

申请人： Paul B. Trost ,  Joyce A. Trost

发明人： Paul B. Trost ,  Joyce A. Trost

IPC分类号： A61K8/9794 ,  A61K31/255 ,  A61K8/64 ,  A61K8/46 ,  A61K8/67 ,  A61K8/73 ,  A61Q19/08 ,  A61K9/00 ,  A61K36/9068 ,  A61K31/12 ,  A61K38/06 ,  A61K31/10 ,  A61K31/375 ,  A61K31/728 ,  A61K8/35 ,  A61P17/02 ,  A61K36/9066

摘要： A topical composition comprising ginger, curcumin, one or more of glutathione, MSM, Vitamin C, hyaluronic acid, sodium lauryl sulfate, Vitamin D and Vitamin E, and a carrier, wherein each of the glutathione, MSM, Vitamin C, hyaluronic acid, sodium lauryl sulfate, Vitamin D, and Vitamin E. When applied to human skin or animal skin, the composition can improve the appearance of skin and speed up wound healing.

公开(公告)号：US11504411B1

公开(公告)日：2022-11-22

申请号：US17741793

申请日：2022-05-11

申请人： Progressing Bodies, Inc.

发明人： Geovon K Martin

IPC分类号： A61K36/9066 ,  A61K36/185 ,  A61K36/481 ,  A61K36/28 ,  A61K36/31 ,  A61P37/04 ,  A61K31/714 ,  A61K31/355 ,  A61K36/8962 ,  A61K36/53 ,  A61K31/122

摘要： An herbal formulation including effective amounts of cat's claw extract, Astragalus extract, Echinacea extract, Moringa extract; astaxanthin, black elderberry extract, vitamin B12, blackseed extract, oregano extract; garlic extract; tumeric extract, and vitamin E provides nutritional support for healthy immune function. The herbal formulation may be packaged in dosage forms that are particularly effective in fighting infections, and especially viral infections.

公开(公告)号：US20220323535A1

公开(公告)日：2022-10-13

申请号：US17714553

申请日：2022-04-06

申请人： Core Essentials, Inc.

发明人： Jia Yia Liu ,  Lisa Ma

IPC分类号： A61K36/9066 ,  A61K31/198 ,  A61K31/122 ,  A61K36/87 ,  A61K36/82 ,  A61K36/185 ,  A61K31/352 ,  A61K38/48 ,  A61K36/068 ,  A61K31/164 ,  A61K31/07 ,  A61K31/51 ,  A61K31/525 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/714 ,  A61K31/375 ,  A61K31/593 ,  A61K33/32 ,  A61K33/30 ,  A61K33/04

摘要： A multi-component health supplement for improving overall wellness and modulating the immune system is provided as a mixture of N-acetyl-L-cysteine (NAC), quercetin, bromelain, Cordyceps, turmeric extract (curcumin), palmitoylethanolamide (PEA), grape seed extract, green tea extract, elderberry extract, pomegranate extract, and astaxanthin, and optionally one or more vitamins and minerals. Various subcombinations for targeting cellular health, fatigue, oxidative degradation, and other specific health needs are also provided.

公开(公告)号：US20220218649A1

公开(公告)日：2022-07-14

申请号：US17143553

申请日：2021-01-07

申请人： Mai Nguyen

发明人： Mai Nguyen

IPC分类号： A61K31/352 ,  A61K31/05 ,  A61K9/48 ,  A61K31/015 ,  A61K36/07 ,  A61K36/9066 ,  A61K36/752 ,  A61K36/67 ,  A61K36/258 ,  A61K36/53

摘要： A composition for treating opioid withdrawal and method of manufacture and administration of the composition creates a synergistic combination of cannabinoids, terpenoids, herbs, and medicinal mushrooms that help to eliminate the symptoms of opioid withdrawal by creating a medicinal entourage. The composition combines: between about 2.5 to 100 milligrams of a cannabinoid, between about 0.084 to 33.6 milligrams of a terpenoid, between about 0.5 to 3000 milligrams of an herb, and between about 25 to 2500 milligrams of a medicinal mushroom. The composition is orally administered in a lipid-enclosed capsule form. The terpenoid has a lipophilic nature that enhances the bioavailability of the cannabinoid. The herb works with the body's endocannabinoid system to enhance pain relief capacity of the cannabinoid, so as to help inhibit symptoms of opioid withdrawal. The medicinal mushroom comprises a psychedelic drug that creates a therapeutic effect with the cannabinoid to inhibit symptoms of opioid withdrawal.

公开(公告)号：US20220202713A1

公开(公告)日：2022-06-30

申请号：US17698389

申请日：2022-03-18

申请人： AQUANOVA AG

发明人： Dariush Behnam

IPC分类号： A61K9/107 ,  A61K31/12 ,  A61K9/48 ,  A23L2/56 ,  A61K36/9066 ,  A61K47/26 ,  A23L33/10 ,  A23L2/52 ,  A23L2/39 ,  A23P10/30 ,  A23D7/005 ,  A23L5/43 ,  A23L27/10 ,  A61K31/121 ,  A23L33/105

摘要： A solubilize composed of curcumin in a quantity of less than or equal to 10% by weight, preferable less than or equal to 7.5% by weight, particularly preferable 6% by weight, and at least one emulsifier having an HLB value in the range between 13 and 18, in particular polysorbate 80 or polysorbate 20 or a mixture of polysorbate 20 and polysorbate 80, wherein the average diameter of the micelles loaded with curcumin in between 5 nm and 40 nm, preferable between 6 nm and 20 nm, particularly preferable between 7 nm and 10 nm.

公开(公告)号：US11369653B2

公开(公告)日：2022-06-28

申请号：US17048438

申请日：2018-07-23

申请人： Hongzhang Jia

发明人： Hongzhang Jia

IPC分类号： A61K36/236 ,  A61P7/02 ,  A61P9/10 ,  A61P9/04 ,  A61K9/00 ,  A61K36/21 ,  A61K36/46 ,  A61K36/88 ,  A61K36/9066

摘要： A traditional Chinese medicine composition for treating cardiovascular and cerebrovascular disease, the active ingredients thereof being composed of: 1) an ethanol extract of 6-12 parts of Ligusticum wallichii and 5-10 parts of Curcumae Radix, and 2) an aqueous extract of extract residue of the described Ligusticum wallichii and Curcumae Radix and 5-10 parts of Radix Cyathulae; the traditional Chinese medicine composition may further comprise an aqueous extract of 5-10 parts of Allium macrostemon and 6-12 parts of Eucommia ulmoides. The traditional Chinese medicine composition relates to medicine made from plant compounds, and has significant medicinal effects on myocardial contraction disorder and myocardial dilation disorder, platelet aggregation thrombosis and myocardial ischemia, myocardial hypoxia, myocardial fatigue, and so on, being particularly suitable for treating coronary heart disease and chronic or acute heart failure.